by The global clinical trial ecosystem is enormous and continues to expand across pharmaceutical, biotechnology, medical device, and advanced therapy development. However, there is no single perfect worldwide ranking because multinational trials can be registered in multiple databases and sponsors may appear under different legal entities.
The WHO’s International Clinical Trials Registry Platform (ICTRP) brings together trial records from registries worldwide and attempts to group multiple records relating to the same trial. WHO data are updated regularly, making ICTRP an important source for understanding the global research landscape.
Meanwhile, the U.S. government-run ClinicalTrials.gov listed 593,857 registered studies across 226 countries and territories as of July 14, 2026. Of these, 453,135, or 76%, were interventional studies, while 219,299 involved drugs or biologics.
So, which companies stand out among the biggest clinical trial sponsors?
AstraZeneca: One of the Most Active Pharma Trial Sponsors
AstraZeneca is consistently among the most active pharmaceutical companies in clinical research, particularly in oncology, cardiovascular, renal and metabolic diseases, and respiratory conditions.
A January 2026 snapshot of recruiting studies based on ClinicalTrials.gov data identified AstraZeneca as the leading industry sponsor, with 234 recruiting trials.
Its large global development pipeline and focus on multiple therapeutic areas help explain its substantial trial activity.
Novartis: Strong Global Research Activity
Novartis is another major company running a large number of clinical studies worldwide.
The same January 2026 ClinicalTrials.gov snapshot identified 168 recruiting trials sponsored by Novartis, placing it among the most active pharmaceutical industry sponsors.
Its activity spans areas such as oncology, immunology, neuroscience, cardiovascular disease, and other major therapeutic categories.
AbbVie: A Major Clinical Development Player
AbbVie also ranks among the companies with substantial active clinical research programs.
The January 2026 ClinicalTrials.gov-based analysis recorded 135 recruiting trials for AbbVie.
The company’s research activity is supported by major programs across immunology, oncology, neuroscience, eye care, and other therapeutic areas.
Other Major Companies Driving Global Clinical Research
Beyond the snapshot above, companies widely recognized for large-scale global clinical development include:
These companies operate extensive international development programs, although their exact rankings change depending on whether trials are measured by currently recruiting studies, all registered studies, active studies, trial phases, or unique global trials.
Government Data Shows the Scale of Clinical Research
ClinicalTrials.gov data provide a useful view of how rapidly research has expanded. The database grew from 205,318 registered studies at the end of 2015 to 563,828 at the end of 2025. By July 14, 2026, the total had reached 593,857 studies.
There were also 65,004 recruiting studies listed as of July 14, 2026. Of these, 42,836, or 66%, were conducted only outside the U.S., showing the increasingly international nature of clinical research.
AstraZeneca vs. Novartis: Who Is Running More Trials?
Using the January 2026 snapshot of recruiting studies on ClinicalTrials.gov, AstraZeneca led Novartis:
AstraZeneca: 234 recruiting trials
Novartis: 168 recruiting trials
This comparison reflects one specific point-in-time dataset and should not be treated as a permanent worldwide ranking. A company’s trial count can change as studies start, complete, terminate, or update their recruitment status.
For buyers, investors, CROs, and clinical research partners, the more useful question is often not simply “Who has the highest number?” but also:
Which therapeutic areas are they investing in?
How many late-stage trials are underway?
How global is their research footprint?
How quickly are new studies entering the pipeline?
What Does Towards Healthcare Indicate?
According to Towards Healthcare, the expanding pharmaceutical and biotechnology ecosystem is increasing demand for clinical development capabilities across trial design, patient recruitment, data management, monitoring, decentralized trials, and advanced analytics.
The scale of government-registered research supports this trend. With nearly 594,000 studies listed on ClinicalTrials.gov across 226 countries and territories, pharmaceutical companies increasingly require global clinical infrastructure and specialized partners to manage complex development programs.
Explore key healthcare data and trends in our Healthcare Ecosystem Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium
